You are here:
ulipristal (EllaOne)
Advice
Following a full submission
ulipristal acetate (EllaOne®) is accepted for use within NHS Scotland for emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure. When administered within the licensed time frame for ulipristal or an active comparator for emergency hormonal contraception, contraceptive efficacy with ulipristal was non-inferior to that with the comparator in individual studies and statistically superior in a meta-analysis of two studies.
Other treatments are available at lower drug acquisition cost.
Drug Details
| Drug Name: | ulipristal (EllaOne) |
|---|---|
| SMC Drug ID: | 599/10 |
| Manufacturer: | HRA Pharma UK Ltd |
| Indication: | Emergency contraception |
| BNF Category: | |
| Sub Category: | 7.3 Contraceptives |
| Submission Type: | Full submission |
| Status: | Accepted |
| Date Advice Published: | 8 February 2010 |